Vertex Pharmaceuticals Incorporated (0QZU.L) LSE

477.30

+6.6817(+1.42%)

Updated at February 20 06:56PM

Currency In USD

Valuation

Market Cap115.92B
Enterprise Value114.72B
P/E Ratio30.63
PEG Ratio3.85
Price/Sales Ratio10.06
Price/Book Ratio6.49
Enterprise/Revenue9.96
Enterprise/EBITDA24.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.33
Operating Margin0.35

Management Effectiveness

Return On Assets0.15
Return On Equity0.23

Income Statement

Revenue12.07B
Revenue/Share47.41
Gross Profit10.27B
EBITDA4.97B
Net Income3.95B
Diluted EPS15.32

Balance Sheet

Total Cash6.61B
Total Cash/Share26.04
Total Debt3.88B
Total Debt/Equity0.21
Current Ratio2.9
Book Value Per Share73.52

Price History

52-Week Change-0.81
52-Week High479.99
52-Week Low290.87
Moving Average 50 Days424.38
Moving Average 200 Days373.25

Statistics

Average Volume2,907
Shares Outstanding257M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A